Why the study?
Do dietary sphingolipids influence chronic inflammation in metabolic disorders?
Population
Mammalian cells, in vitro models, rodent models, and human clinical trials related to chronic inflammation…
Design
Review
Authors
Loading...
Supports potential anti-inflammatory role of dietary sphingolipids in metabolic disorders; leaves open confirmation in prospective human trials.
Do dietary sphingolipids influence chronic inflammation in metabolic disorders?
Dietary sphingolipids may offer anti-inflammatory benefits in metabolic diseases, though their effects contrast with the generally pro-inflammatory nature of endogenous cellular sphingolipids.
Norris et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: